Ensysce Biosciences, Inc.

announcedU=S+W/2W=S@11.50
ENSCSEC EDGARCIK: 0001716947|Hydra Management, LLC•Pharmaceutical

Capital Structure & Economics

Trust Size$250,000,000
Unit Price$10.00
Warrant Coverage1/2
Sponsor Promote20%

Implied Equity Architecture

Capital Allocation Baseline

Trust (100.0%)

Implied Dilution Drag

50% Warrant Inclusion
Public Trust Allocation$250,000,000
Sponsor At-Risk CapitalN/A
Total Underwriting DiscountN/A
Trust Per Unit (Implied)$10.00
Sponsor Promote Allocation20%
Deal Lifecycle
IPO PricedNov 3, 2017
SearchingTarget Pending
Maturation Wall
N/A

Announced Target / M&A

  • Target CompanyEnsysce
  • SectorPharmaceutical
  • Announced Deal Size$173,336,550

Board & Officers

  • David HumphreyCEO
  • Matthews Lane Capital Partners LLCOfficer
  • HG Vora Special Opportunities Master Fund, Ltd.Officer
  • Hydra SponsorOfficer
  • A. Lorne Weil(4)
    Director
  • George Peng(4)
    Director

Advanced Structuring Terms

Target SectorsPharmaceutical

Syndicate & Advisors

Interactive Deal Modeling

Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.

Dilution Cash Friction